Leukemia Treatment Program
Call today to schedule an appointment with one of our pediatric specialists.
Oncology Referrals
The Leukemia Treatment Program for children and teenagers at the Hyundai Cancer Institute at CHOC is dedicated to providing patients with the most advanced, pediatric leukemia treatment available. We specialize in treating patients’ different types of leukemia, from standard to high-risk acute lymphoblastic leukemia (ALL), very-high-risk ALL and acute myeloid leukemia (AML).
Our cancer specialists provide customized care to meet the specific needs of the patient while also balancing the social and emotional needs of the patient and family. Treatments for children and teenagers are based on the type and stage of leukemia, as well as the most current international protocols and research.
What We Treat
Our leukemia team treats all types of leukemia:
- Acute Lymphoblastic Leukemia (ALL), both B and T cell
- Acute Myeloid Leukemia (AML)
- Acute Promyelocytic Leukemia (APL)
- Chronic Myelogenous Leukemia (CML)
- Juvenile Myelomonocytic Leukemia (JMML)
- Myelodysplastic Syndrome (MDS)
- Ph-positive acute lymphoblastic leukemia
- Relapsed and refractory leukemia
- Transient Myeloproliferative Disorders (TMD)
The pediatric leukemia team also works with patients receiving blood and marrow transplants through the Cancer Institute’s Stem Cell Transplant and Cellular Therapies Program.
Clinical Trials and Research
Children’s and teens cancers are very different than adult cancers and must be treated with specific pediatric cancer protocols. Our experience in exclusively treating children, teens and young adults makes us the experts in the evaluation and treatment of all forms of common childhood and adolescent cancers. We are dedicated to administering the very latest pediatric cancer treatment options. A majority of our protocols come from the Children’s Oncology Group (COG), a national organization funded by the National Cancer Institute (NCI). Our relationship with the COG makes us the only medical center in the southwestern United States offering COG Phase I clinical trials.
Learn more about our ongoing research and the clinical trials available at the Cancer Institute.